Skip to main content

Month: April 2022

Spree Acquisition Corp. 1 Limited Files its Annual Report for the 2021 Year

TEL AVIV, ISRAEL, April 04, 2022 (GLOBE NEWSWIRE) — Spree Acquisition Corp. 1 Limited (NYSE: SHAP, SHAPU and SHAPW) (the “Company”) announced that it filed its annual report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission on March 31, 2022. Copies of the annual report and other filings are available online through the Company’s website, https://www.spree1.com/, or by accessing the Securities and Exchange Commission’s website, www.sec.gov. Copies may also be obtained from the Company, Attn: Shay Kronfeld, CFO & VP Business, 94 Yigal Alon, Building B, 31st floor, Tel Aviv, 6789139, Israel, or by email: sk@spree1.com. About Spree Acquisition Corp. 1 Limited Spree Acquisition Corp. 1 Limited was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition,...

Continue reading

BOK Financial Corporation announces first quarter 2022 earnings conference call

TULSA, Okla., April 04, 2022 (GLOBE NEWSWIRE) — BOK Financial Corporation (NASDAQ: BOKF) will announce financial results for the first quarter of 2022 will be released before market open on Wednesday, April 27, 2022. The company will hold a conference call at 9 a.m. central time that morning to discuss the financial results with investors. The live audio webcast and presentation slides will be available on the company’s investor relations website. The conference call can also be accessed by dialing 1.877.407.4018 toll free, or 1.201.689.8471, conference ID: 13728424. A webcast replay will be available shortly after the live call’s conclusion on the company’s investor relations website or by dialing 1.844.512.2921 and referencing replay PIN 13728424. About BOK Financial CorporationBOK Financial Corporation is a $50 billion...

Continue reading

DZS Named Recipient of Asian Telecom Award for Work with Rakuten Mobile

The Asian Business Review recognizes success of DZS Mobile & Optical Edge solutions in Rakuten Mobile’s pioneering O-RAN mobile network DALLAS, April 04, 2022 (GLOBE NEWSWIRE) — DZS (Nasdaq: DZSI), a global leader in access networking and cloud software solutions, today announced that The Asian Business Review’s Asian Telecom Awards 2022 has recognized the company for its work with Rakuten Mobile, which has deployed and scaled the industry’s first fully virtualized, cloud-native Open RAN (O-RAN) mobile network to millions of subscribers in Japan. The “Infrastructure of the Year” award highlights the role of the DZS Chronos Mobile & Optical Edge solutions in helping the mobile operator manage its 4G and 5G traffic. “Rakuten Mobile has been a valued partner for DZS since 2019, and I am extremely proud of the groundbreaking...

Continue reading

Teck Contributes $2.5 million to New ‘Teck Emergency Department’ Featuring Antimicrobial Copper at Royal Inland Hospital

KAMLOOPS, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) — Royal Inland Hospital Foundation and Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced that Teck has made a $2.5 million contribution towards the hospital’s new emergency department. The new Teck Emergency Department will feature the installation of innovative antimicrobial copper surfaces and equipment to help protect patients and healthcare workers. When complete, the newly renovated emergency department will offer expanded care and enhanced patient outcomes in one of the busiest emergency departments in British Columbia’s Interior region. The facility upgrades will result in reduced wait times for access to treatment for people when they need it most. Teck’s donation will also facilitate innovation within the department, including...

Continue reading

Buybacks of shares in Bilia AB during week 13, 2022

During the period between March 28 and April 1, 2022 Bilia AB (LEI code 2138002GW5WN1UYZA032) has repurchased in total 209,498 own shares (ISIN SE0009921588 ) as part of the buyback program initiated by the Board of Directors in order to optimize the company’s capital structure. The share buybacks form a part of the buyback program of a maximum of 3,000,000 shares for a total maximum amount of SEK 500 M, which Bilia AB announced on January 19, 2022. The buyback program, which runs between February 9, 2022 – April 7, 2022, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the ”Safe Harbour Regulation”). The objective of the share buybacks is to optimize the company’s capital structure and the intention is to reduce Bilia’s share capital...

Continue reading

Monthly disclosure on share capital and voting rights March 31, 2022

Regulated informationIssy-les-Moulineaux, April 4, 2022 Monthly disclosure on share capital and voting rightsPursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorités des Marchés Financiers Registered name of the issuer: SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUXDate Total number of shares Actual voting rights * Theoretical voting rights **March 31, 2022147,454,887215,991,634217,262,963* Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights.** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having either...

Continue reading

SCYNEXIS to Participate in Upcoming April Women’s Health Medical Conferences

JERSEY CITY, N.J., April 04, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced participation in three women’s health conferences in April. “As the creator of the first oral treatment for vaginal yeast infection approved in the Unites States in more than 20 years, our scientific teams are extremely proud to be at the forefront of research and development for new groundbreaking treatments in the underserved area of women’s health,” said Marco Taglietti, M.D., President and Chief Executive Officer of SCYNEXIS, “We look forward to having an opportunity during these meetings to join medical colleagues from around the country to discuss and learn details about important advancements in...

Continue reading

UCASU may report more profits for both 2021 and 2020 upon changing accounting

Atlanta, April 04, 2022 (GLOBE NEWSWIRE) — UC Asset LP (OTCQX: UCASU) management announces that the company may report better profit results for both its fiscal years of 2021 and 2020, after the Company switched its accounting method from fair market value accounting to historical cost accounting. Previously, the Company reported close to zero profit for fiscal year 2020, and it projected a $0.10 per share operating profit ($0.13 per share net equity gain including the gains from buybacks) for fiscal year 2021. However, last week the Company filed a Form 8-K, which announced the accounting method change, and declared that its previously financial reports, as well as projections, should no longer be relied upon. The change of accounting method was a decision by the Company’s management, in light of SEC (Security and Exchange Commission)...

Continue reading

Nymox Announces Closing of $6.4 Million Financing

IRVINE, Calif., April 04, 2022 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has closed its $6.4 million financing announced in its filing of March 22 with institutional and accredited investors consisting of 3,878,789 common shares at a purchase price of $1.65 per share, sold pursuant to a registered direct offering. The Company has also issued to the investors, in a concurrent private placement, unregistered warrants to purchase up to an aggregate of 3,878,789 common shares. The warrants have an exercise price of $2.00 per share and will expire 5 years from the date of an effective registration statement covering the shares underlying the warrants. Nymox is also pleased to report that the offering has the strong support of long-term shareholders and would like...

Continue reading

Rail Vision Ltd. Announces Closing of $15.6 Million Initial Public Offering

Ra’anana, Israel, April 04, 2022 (GLOBE NEWSWIRE) — Rail Vision Ltd. (the “Company”) (Nasdaq: RVSN), a development stage technology company that is seeking to revolutionize railway safety and the data-related market, today announced the closing of its initial public offering of 3,787,241 ordinary shares and accompanying warrants to purchase 3,787,241 ordinary shares. Each ordinary share was sold together with one warrant to purchase one ordinary share with an exercise price of $4.13 at a combined public offering price of $4.13 per share and accompanying warrant. Gross proceeds for the offering were approximately $15.6 million, before deducting underwriting discounts and commissions and estimated offering expenses. The Company granted Aegis Capital Corp, the underwriter (“Aegis”), a 45-day over-allotment option to purchase additional...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.